From Novo Nordisk, TransLoc, Duke Energy, & More NC Innovation News:

Novolin—

Novo Nordisk’s Novolin, insulin made from recombinant DNA. Photo courtesy of Flickr user Melissa Johnson via a Creative Commons license https://www.flickr.com/photos/ladytaz/

Underwriters and Partners

Xconomy Insight

Xconomy Insight · Special Report
How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook
Insights, wisdom, and inspiration on what it takes

From Our Editors · Special Report
2019 Biopharma Outlook – Facing an Uncertain Future
Key indicators & expert insight from industry leaders
Xconomy

From Our Partners · Special Report
Robert Langer reveals secrets to early-stage biotech success
Advice for funding and future transformational opportunities

Xconomy on Demand

We offer a number of ways to subscribe for free!

Subscribe Now

Xconomy Boston

Lundbeck’s Alder Bio Bet Pays Off With FDA Approval of Migraine Drug

Invetx Fetches $15M to Develop Biologic Drugs for Man’s Best Friend

BioIntelliSense Debuts "Sticker” Sensor to Capture Patient Data Remotely

Esperion’s FDA-Approved Cholesterol Drug Priced Even Lower Than Expected

Eli Lilly Gets Skin in the Eczema Game With $1.1B Deal for Dermira

Agile Therapeutics Wins FDA Nod for Twirla Contraceptive Patch

Dova Pharmaceuticals Agrees to Sobi Acquisition, Shares Jump 38%

Ligand’s Icagen Deal Brings Neuro, CF Assets Plus Partnering Potential

NGM Bio’s NASH Drug Shows Promise, Shares Rise on Early Phase 2 Data

SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal

Reata’s Kidney Drug Hits Goals of Key Study, Paves Way for FDA Filing

AI Can Unlock Health Data's Potential, But Access Is Still Difficult

BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic

After AstraZeneca, Osbourn Reflects on Roles at CAT & MedImmune

Xcelerating Life Sciences San Diego

Xcelerating Life Sciences Boston

Xcelerating Life Sciences Philadelphia

From Novo Nordisk, TransLoc, Duke Energy, & More NC Innovation News:

Underwriters and Partners

How to Jump 5 Unforeseen Hurdles to Biotech Success – Startup Sourcebook

2019 Biopharma Outlook – Facing an Uncertain Future

Robert Langer reveals secrets to early-stage biotech success

Xconomy on Demand

We offer a number of ways to subscribe for free!